|
Market Closed -
Nasdaq
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 128.00 USD | -0.64% |
|
+0.20% | +29.59% |
| 01/09 | Incyte Corporation Enters Agreement with U.S. Centers for Medicare & Medicaid Services | CI |
| 29/08 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| Market Cap | 2.61TCr 2.25TCr 2.11TCr 1.93TCr 3.6TCr 2,46900Cr 3.63TCr 25TCr 9.71TCr 1,26200Cr 9.81TCr 9.59TCr 4,06300Cr | P/E 2026 * |
57.5x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.19TCr 1.88TCr 1.77TCr 1.62TCr 3.02TCr 2,06900Cr 3.04TCr 21TCr 8.14TCr 1,05700Cr 8.22TCr 8.04TCr 3,40500Cr | EV / Sales 2026 * |
3.68x | EV / Sales 2027 * | 3.21x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INCY | Delayed | |
CBOE
| INCY | Real-time | |
|
Mexican S.E.
| INCY * | End-of-day quote | |
|
Boerse Muenchen
| ICY | Real-time | |
|
Berne S.E.
| ICY | End-of-day quote | |
|
Tradegate
| ICY | Real-time | |
|
Deutsche Boerse AG
| ICY | Delayed | |
|
Xetra
| ICY | Delayed | |
|
Börse Stuttgart
| ICY | Delayed | |
|
Borsa Italiana
| 1INCY | End-of-day quote |
Last Transcript : Incyte Corporation
| 1 day | -0.64% | ||
| 1 week | +0.20% | ||
| Current month | +3.88% | ||
| 1 month | +8.08% | ||
| 3 months | +30.64% | ||
| 6 months | +30.52% | ||
| Current year | +29.59% |
| 1 week | 121.61 |  | 130 |
| 1 month | 115.77 | | 130.8 |
| Current year | 89.25 | | 132.6 |
| 1 year | 81.09 | | 132.6 |
| 3 years | 50.27 | | 132.6 |
| 5 years | 50.27 | | 132.6 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 04/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Tax | EVP, Human Resources | -504 | 0.0002% | ||
| 19/08/26 | Sell | Chairperson | -10,801 | 0.0053% | ||
| 12/08/26 | Sell | Chairperson | -10,803 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | +0.20% | +47.19% | +102.28% | 2.61TCr | |
| -1.00% | +4.43% | +49.60% | +2.50% | 8.51TCr | |
| -1.29% | +4.27% | +519.00% | +36.13% | 6.02TCr | |
| +0.95% | +1.77% | -15.77% | -34.78% | 5.97TCr | |
| -1.60% | -7.63% | -3.65% | +31.05% | 5.11TCr | |
| +0.09% | -0.14% | +11.61% | +165.71% | 4.87TCr | |
| +0.83% | +1.36% | +58.53% | -15.69% | 3.29TCr | |
| +0.79% | -6.56% | -2.56% | +192.31% | 2.26TCr | |
| +1.10% | -0.90% | +67.27% | +118.01% | 1.64TCr | |
| -5.19% | -9.15% | -20.45% | +740.91% | 1.53TCr | |
| Average | -0.68% | -2.42% | +71.08% | +133.84% | 4.18TCr | |
| Weighted average by Cap. | -0.64% | -1.18% | +92.78% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 594.19Cr 511.24Cr 479.76Cr 438.94Cr 819.26Cr 56TCr 825.75Cr 5.68TCr 2.21TCr 29TCr 2.23TCr 2.18TCr 92TCr | 626.5Cr 539.04Cr 505.85Cr 462.81Cr 863.81Cr 59TCr 870.65Cr 5.98TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 97TCr |
| Net income | 47Cr 40Cr 38Cr 34Cr 64Cr 4.4TCr 65Cr 444.94Cr 173.28Cr 2.25TCr 174.93Cr 171.11Cr 7.25TCr | 149.59Cr 128.7Cr 120.78Cr 110.5Cr 206.25Cr 14TCr 207.88Cr 1.43TCr 556.41Cr 7.23TCr 561.72Cr 549.47Cr 23TCr |
| Net Debt | -422.97Cr -363.92Cr -341.51Cr -312.45Cr -583.18Cr -40TCr -587.8Cr -4.04TCr -1.57TCr -20TCr -1.59TCr -1.55TCr -66TCr | -599.09Cr -515.46Cr -483.71Cr -442.56Cr -826.01Cr -57TCr -832.55Cr -5.72TCr -2.23TCr -29TCr -2.25TCr -2.2TCr -93TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $128.00 | -0.64% | 9,00,291 |
| 02/26/02 | $128.83 | +3.06% | 23,24,205 |
| 01/26/01 | $125.01 | +1.45% | 11,91,993 |
| 31/26/31 | $123.22 | -0.92% | 14,83,195 |
| 28/26/28 | $124.37 | -2.64% | 12,15,069 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
